NeuroSense Therapeutics Ltd. Reclassifications of Temporary to Permanent Equity
NeuroSense Therapeutics Ltd. (NRSN) reported Reclassifications of Temporary to Permanent Equity of $1.37 million for the 12-month period ending 2024-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Shareholders' Equity
us-gaap:ReclassificationsOfTemporaryToPermanentEquity · last filed 2026-03-31
| Period end | Reclassifications of Temporary to Permanent Equity 6 month | Reclassifications of Temporary to Permanent Equity 12 month |
|---|---|---|
| 2024-12-31 | $1.37M 20-F · filed 2026-03-31 | |
| 2024-06-30 | $1.70M 6-K · filed 2025-08-01 |